Today: 9 June 2026
Chevron stock jumps on Trump’s Venezuela oil pivot; CVX eyes Jan. 30 earnings call

Chevron stock jumps on Trump’s Venezuela oil pivot; CVX eyes Jan. 30 earnings call

New York, January 5, 2026, 09:54 EST — Regular session

  • Chevron shares rose nearly 4% early Monday on headlines tied to U.S. moves in Venezuela.
  • Refiners and other energy names climbed as traders assessed potential changes to heavy-crude flows.
  • Investors now watch for policy details and Chevron’s Jan. 30 earnings call.

Chevron shares jumped on Monday after President Donald Trump said the United States would take control of Venezuela following the arrest of President Nicolas Maduro and that U.S. oil companies would help rebuild the country’s oil industry. The stock was up 3.8% at $161.87 in early trade, after touching $171.50 soon after the open. Trump said an embargo on Venezuelan oil exports would remain in place for now.

The headlines matter for Chevron because any shift in U.S. policy toward Venezuela would put a premium on speed and existing relationships. For producers, the upside is access to reserves and projects; for refiners, it is about feedstock.

Venezuelan crude is often described as “heavy sour” — thick and sulfur-rich — the kind of oil many U.S. Gulf Coast refineries were built to process. That linkage helps explain why the move spilled beyond drillers into refining names.

The rally was not confined to Chevron. Exxon Mobil was up 1.6% and ConocoPhillips rose 4.1%, while refiner Valero gained 9.2% in early trade. Wall Street opened higher more broadly, with the S&P 500 up about 0.5% at the bell.

Investors are still trying to separate tradable headlines from the operational grind of restoring output. Venezuela’s oil industry has suffered from years of sanctions and underinvestment, and any meaningful ramp would likely require time, capital and clearer rules.

“While the capture of Venezuelan president Maduro by American forces has dominated headlines, financial markets seem unperturbed,” Thomas Mathews of Capital Economics said in a report. Venezuela’s current oil output is about 1.1 million barrels a day, and some analysts expect it could rise sharply if investment returns, the report noted. WRAL News

But the fast money risk is straightforward: the policy path may not match the market’s first reaction. With the embargo still in place, traders said the timeline for any change — and who benefits most — remains the key uncertainty.

The next test for the trade is whether Washington provides specifics on licenses, sanctions and oversight that would govern any corporate return. Refiners will also watch heavy-crude price spreads and product margins, which can swing quickly when supply assumptions shift.

Chevron said it will hold its fourth-quarter 2025 earnings conference call on Friday, January 30, at 11:00 a.m. ET, with CEO Mike Wirth and CFO Eimear Bonner scheduled to speak. The event could become a focal point for questions on Venezuela exposure, capital commitments and shareholder returns.

Until then, traders will track any formal U.S. steps on Venezuela policy and whether Chevron’s early spike can hold as the headline premium fades. The next clear catalyst for CVX is that January 30 earnings call.

Stock Market Today

  • Aker BP Share Price Surges Amid Valuation Debate
    June 9, 2026, 11:54 AM EDT. Aker BP (OB:AKRBP) shares climbed to NOK347.7, marking a 55.05% total shareholder return over one year, outperforming peers in Norway's energy sector. Despite this momentum, the stock trades at an 8.6% premium over a fair value of NOK320.11, raising questions about valuation. The company aims to sustain production above 500,000 barrels per day past 2030, backed by projects like Yggdrasil and Johan Sverdrup, supporting revenue growth. Yet, potential risks include higher emissions costs and delays in key developments. Analysts offer cautious pricing, but a discounted cash flow (DCF) model from Simply Wall St suggests a much higher intrinsic value of NOK1,769.75, indicating significant undervaluation. Investors face a valuation divide between conservative targets and optimistic cash flow projections.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks
Previous Story

BAE Systems shares jump nearly 5% as Venezuela shock lifts European defense stocks

Applied Digital (APLD) stock jumps 6% as earnings loom and ChronoScale deal stays in focus
Next Story

Applied Digital (APLD) stock jumps 6% as earnings loom and ChronoScale deal stays in focus

Go toTop